Edition:
India

Varian Medical Systems Inc (VAR.N)

VAR.N on New York Stock Exchange

120.17USD
20 Feb 2018
Change (% chg)

$-1.09 (-0.90%)
Prev Close
$121.26
Open
$120.65
Day's High
$121.79
Day's Low
$119.75
Volume
342,223
Avg. Vol
221,988
52-wk High
$130.28
52-wk Low
$82.80

Select another date:

Tue, Feb 6 2018

BRIEF-Varian Halcyon Treatment System Receives AERB Certificate For Import & Supply In India

* VARIAN HALCYON TREATMENT SYSTEM RECEIVES AERB CERTIFICATE FOR IMPORT & SUPPLY IN INDIA

BRIEF-Varian Acquires Mobius Medical Systems

* VARIAN SAYS IT HAS ACQUIRED PRIVATELY-HELD MOBIUS MEDICAL SYSTEMS Source text for Eikon: Further company coverage:

UPDATE 2-Varian Medical swoops on Australia's Sirtex as medical M&A soars

* Sirtex, Varian shares yet to trade since announcement (Recasts, adds Sirtex background and analysts' quotes)

Varian Medical Systems to buy Australia's Sirtex Medical for about $1.3 bln

Jan 30 Sirtex Medical Ltd said on Tuesday it has struck a deal with Varian Medical Systems under which Varian agreed to buy the Australian medical device company in a deal that valued it at about A$1.6 billion ($1.29 billion).

BRIEF-Varian Says Signs Agreement To Acquire Sirtex

* ‍ACQUISITION HAS BEEN UNANIMOUSLY APPROVED BY BOARD OF DIRECTORS OF EACH COMPANY​ Source text for Eikon: Further company coverage:

BRIEF-Sirtex Medical Says Board Recommends Acquisition By Varian Medical Systems

* ‍ENTERED BINDING SCHEME IMPLEMENTATION DEED WITH VARIAN MEDICAL SYSTEMS; VARIAN TO ACQUIRE SIRTEX BY WAY OF A SCHEME OF ARRANGEMENT​

BRIEF-Varian Q1 Loss Per Share $1.22 From Continuing Operations

* VARIAN REPORTS RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2018

BRIEF-Varian Medical Systems Sees FY 2018 Adjusted EPS Of $4.05 To $4.17 From Continuing Operations

* SAYS NOW SEES FY 2018 ADJUSTED EARNINGS PER SHARE OF $4.05 TO $4.17 FROM CONTINUING OPERATIONS - SEC FILING

BRIEF-Varian Medical Systems Signed MoU With Ping An Health Technology

* VARIAN MEDICAL SYSTEMS - SIGNED MOU WITH PING AN HEALTH TECHNOLOGY TO EXPLORE STRATEGIC PARTNERSHIP FOR EXPANDING ACCESS TO CANCER CARE IN CHINA Source text for Eikon: Further company coverage:

BRIEF-Varian Halcyon Treatment System Receives Taiwan FDA Approval

* VARIAN HALCYON TREATMENT SYSTEM RECEIVES TAIWAN FDA APPROVAL

Select another date: